Exploring Alcoholism Drug’s Potential Against Brain Tumors

November 29, 2012 - Dr. Sandra Dunn's team at UBC department of paediatrics simultaneously publishes data that corresponds with $2.5 million grant winning research at Swedish Medical Center identifying Disulfaram as having potential for brain cancer treatment.

Read the full article here ...

Previous
Previous

Groundbreaking research in triple-negative breast cancer provides hope

Next
Next

Stem Cell Killer Could Lead to Triple-Negative Breast Cancer 'Game Changer'